Syndax Pharmaceuticals Inc·4

Feb 3, 4:52 PM ET

Katkin Keith 4

4 · Syndax Pharmaceuticals Inc · Filed Feb 3, 2023

Insider Transaction Report

Form 4
Period: 2023-02-02
Katkin Keith
Director
Transactions
  • Award

    Common Stock

    2023-02-02+16,00048,000 total
Footnotes (1)
  • [F1]Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT